3 terminated, 2 completed. 2 Phase 1, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Concordia Laboratories Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Establishment of a PDT Patient Registry No intervention - Lung Cancer | Terminated | Concordia Laboratories Inc. | 22 | 2019-01-18 | 2020-02-24 | |
| Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction Photodynamic Therapy, Argon Plasma Coagulation - Non Small Cell Lung Cancer | Not applicable | Terminated | University of Florida | 3 | 2018-10-11 | 2019-12-18 |
| Safety of PDT-Photofrin® Prior to Lung Surgery Porfimer Sodium, Fiber optic - Lung Cancer, Lung Cancer Metastatic | Phase 1 | Completed | Concordia Laboratories Inc. | 10 | 2017-08-14 | 2020-01-13 |
| Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer Porfimer sodium, Fiber optic - Non-small Cell Lung Cancer (NSCLC), Lung Metastasis | Phase 1 | Completed | Concordia Laboratories Inc. | 5 | 2017-01-26 | 2020-03-04 |
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) Photodynamic therapy-Photofrin, Stenting procedure, Chemotherapy regimen - Hilar Cholangiocarcinoma | Phase 3 | Terminated | Concordia Laboratories Inc. | 28 | 2014-11-12 | 2019-08-28 |
Lung Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Bile Duct Neoplasms (1) · Cholangiocarcinoma (1) · Klatskin Tumor (1) · Neoplasm Metastasis (1)
Dihematoporphyrin Ether (2) · Optical Fibers (2) · Argon Plasma Coagulation (1) · Cisplatin (1) · Drug Therapy (1) · Gemcitabine (1) · Photochemotherapy (1)
United States (5) · Canada (2) · Germany (1) · South Korea (1) · Switzerland (1)
Erin O'Neil (1) · Michael Jantz, MD (1) · Michel Kahaleh, MD (1) · Michelle Depot, Ph.D. (1) · Sandra Gollnick, Ph.D. (1)